SpringWorks Therapeutics News

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Springworks Therapeutics (SWTX)

TipRanksJul 2 07:05 ET

Barclays Issues a Buy Rating on Springworks Therapeutics (SWTX)

TipRanksJul 2 07:02 ET

SpringWorks Therapeutics Analyst Ratings

BenzingaJun 4 06:50 ET

Analysts Offer Insights on Healthcare Companies: Springworks Therapeutics (SWTX), Cyclo Therapeutics (CYTH) and Oncternal Therapeutics (ONCT)

TipRanksMay 31 06:32 ET

SpringWorks Therapeutics Analyst Ratings

BenzingaMay 31 06:17 ET

SpringWorks Therapeutics Analyst Ratings

BenzingaMay 6 06:36 ET

Analysts Conflicted on These Healthcare Names: Springworks Therapeutics (SWTX) and Becton Dickinson (BDX)

TipRanksMay 6 03:05 ET

Wedbush Raises SpringWorks Therapeutics' Price Target to $75 From $70, Keeps Outperform Rating

MT NewswiresMay 2 12:29 ET

Buy Rating for Springworks Therapeutics Amid Strong Market Performance and Promising Pipeline

TipRanksMay 2 09:45 ET

Springworks Therapeutics (SWTX) Receives a Buy From Barclays

TipRanksMay 2 04:00 ET

Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Springworks Therapeutics (SWTX) and Genmab (GMAB)

TipRanksMar 6 06:46 ET

SpringWorks Therapeutics Analyst Ratings

BenzingaMar 6 06:41 ET

Analysts' Top Healthcare Picks: Ligand Pharma (LGND), Springworks Therapeutics (SWTX)

TipRanksFeb 29 06:30 ET

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Tarsus Pharmaceuticals (TARS) and Springworks Therapeutics (SWTX)

TipRanksFeb 28 05:50 ET

Springworks Therapeutics: A Buy Rating on Ogsiveo's Success and Promising Pipeline

TipRanksFeb 28 05:50 ET

SpringWorks Therapeutics Analyst Ratings

BenzingaFeb 26 09:42 ET

Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Exact Sciences (EXAS) and Springworks Therapeutics (SWTX)

TipRanksFeb 26 08:00 ET

Goldman Sachs Sticks to Their Buy Rating for Springworks Therapeutics (SWTX)

TipRanksFeb 26 06:19 ET

SpringWorks Therapeutics Analyst Ratings

BenzingaJan 25 09:56 ET

Analyst Ratings for SpringWorks Therapeutics

BenzingaNov 29, 2023 08:00 ET